Donald Jones used to pay at least $500 a month for a brand-name drug, Gleevec, thats kept his leukemia at bay for five years. Lately, hes been paying almost as
John Krahne received alarming news from his doctor last December. His brain tumors were stable, but his lung tumors had grown noticeably larger. The doctor recommended a drug called Alecensa,
With another day, another headline arrives revealing the arrogant, out-of-touch nature of the pharmaceutical industry. Fortunately, this time, the outrage arrives from overseas. Specifically, the UK Independent reports that Aspen
Last week, Dr. Pearl kicked off a three-part series on economic biases in medicine. His first installment revealed how money motivates bias in medical research. Today’s article follows the money
Maksim Tsvetovat and Tatyana Kanzaveli say they doubt they could have started their data-collection company, Open Cancer Network, without Obamacare. Tsvetovat, 37 and the father of a four-year-old boy, said
The government of India won a landmark case earlier this year against the drug’s inventor, Novartis, by rejecting the company’s patent on a crystallised form of the drug, allowing generics
Obamacare is going to degrade medicine but its ill effects will fall disproportionately on patients with serious conditions, especially those diagnosed with cancer. The legislation contains provisions that directly target
